Author

I. Monjo

Hospital Universitario La PazORCID 0000-0002-3252-8016Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

I. Monjo1 paper

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

Beatriz Nieto-CarvalhaliD· 2 shared Eugenio de MigueliD· 2 shared María‐Eugenia Miranda‐CarúsiD· 2 shared Sara GarcíaiD· 2 shared Alejandro BalsaiD· 1 shared Alejandro VillalbaiD· 1 shared C. Bohórquez HerasiD· 1 shared Claudia Campos-FabreiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Beatriz Nieto-CarvalhalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Double-Negative B Cell Expansion Defines a Relapse-Prone Immunophenotype in Newly Diagnosed Giant Cell Arteritis

Beatriz Nieto-Carvalhal, I. Monjo, Claudia Campos-Fabre, Sara García, C. Bohórquez Heras, Alejandro Villalba, Diana Peiteado, Eugenio de Miguel, María‐Eugenia Miranda‐Carús

The paper identifies expanded CD27-IgD-double-negative B cells as a biomarker for relapse in newly diagnosed giant cell arteritis.

bioRxiv · Oct 1, 2026 · PreprintImmunology

Circulating PD-1hi CXCR5- and CXCR5+ CD4 T cells are elevated in patients with newly diagnosed Giant Cell Arteritis and predict relapse

I. Monjo, Beatriz Nieto-Carvalhal, Mariela Uyaguari, Sara García, Alejandro Balsa, Eugenio de Miguel, María‐Eugenia Miranda‐Carús

The paper examines circulating PD-1hi CXCR5- and CXCR5+ CD4 T cells in newly diagnosed GCA patients and finds they predict relapse.

Rheumatology · Jan 3, 2025Peer-reviewedImmunology